The DOI matches its Crossref record.
Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
Abstract
PGE2 is known to inhibit IL-2 and IFN-gamma production from Th cells and is widely viewed as a general immunosuppressant. However, PGE2 was found not to inhibit IL-4 production from Th2 clones, and IL-5 production from these clones was slightly enhanced. The same results were obtained with short term T cell lines, which indicates that the lack of inhibition of IL-4 and IL-5 production by PGE2 is a general phenomenon. PGE2 functions by increasing cAMP levels through activation of adenylate cyclase. Despite its failure to inhibit lymphokine release, PGE2 was capable of increasing cAMP levels in Th2 cells, and forskolin, a direct activator of adenylate cyclase, also did not inhibit IL-4 or IL-5 production. These data indicate that the failure of PGE2 to inhibit IL-4 and IL-5 production was not due to an inability of PGE2 to induce an increase in intracellular cAMP, and suggested instead that the expression of IL-4 and IL-5 in Th2 cells is insensitive to elevated cAMP levels. When Th0 clones were examined, PGE2 was again found to differentially affect IL-2 and IL-4 production in three of five clones tested. In two additional Th0 clones, both IL-2 and IL-4 production were inhibited. These data suggest that lymphokine production may be regulated on two different levels. First, Th1- and Th2-associated lymphokines may be differentially sensitive to intracellular signals such as cAMP. Second, T cell subsets may exist, including subsets of Th0 cells, with different signaling pathways. In addition, our data suggest that PGE2 may play an important role in regulating the development of a response dominated by Th1- or Th2-associated lymphokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Human and animal dirofilariasis: The emergence of a zoonotic mosaic
Simón, F., Siles-Lucas, M., Morchón, R., González-Miguel, J., Mellado, I., Carretón, E., & Montoya-Alonso, J. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-12 · Cited by 834
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J., & Aarden, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.775 · Cited by 666
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Immune modulation by mesenchymal stem cells
Jiang, W., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12712 · Cited by 650
Multifaceted roles of PGE2 in inflammation and cancer
Nakanishi, M., & Rosenberg, D. W. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0342-8 · Cited by 591
Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto, Y., & Narumiya, S. (2009) · Nature Medicine · doi:10.1038/nm.1968 · Cited by 566
A new view of prostaglandin E regulation of the immune response
Phipps, R. P., Stein, S. H., & Roper, R. L. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90064-z · Cited by 523
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors
Kawahara, K., Hohjoh, H., Inazumi, T., Tsuchiya, S., & Sugimoto, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.008 · Cited by 488
Dietary modification of inflammation with lipids
Calder, P. C. (2002) · Proceedings of the Nutrition Society · doi:10.1079/pns2002166 · Cited by 485
Premature Ovarian Failure and Ovarian Autoimmunity*
Hoek, A., Schoemaker, J., & Drexhage, H. A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0291 · Cited by 439
Tumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
The innate immune response of the respiratory epithelium: Innate immunity in the airway
Diamond, G., Legarda, D., & Ryan, L. K. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917304.x · Cited by 422
FU, S., RAMANUJAM, K., WONG, A., FANTRY, G., DRACHENBERG, C., JAMES, S., MELTZER, S., & WILSON, K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70496-8 · Cited by 408
Wilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., & Peters-Golden, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117866 · Cited by 392
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Braun, D., Longman, R. S., & Albert, M. L. (2005) · Blood · doi:10.1182/blood-2005-03-0979 · Cited by 391
Kaliński, P., Vieira, P. L., Schuitemaker, J. H. N., de Jong, E. C., & Kapsenberg, M. L. (2001) · Blood · doi:10.1182/blood.v97.11.3466 · Cited by 362
Differential Regulation of Murine T Lymphocyte Subsets
Fitch, F. W., McKisic, M. D., Lancki, D. W., & Gajewski, T. F. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000333 · Cited by 341
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443 · Cited by 332
Role of Antibiotics and Fungal Microbiota in Driving Pulmonary Allergic Responses
Noverr, M. C., Noggle, R. M., Toews, G. B., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4996-5003.2004 · Cited by 330
Harbige, L. S. (2003) · Lipids · doi:10.1007/s11745-003-1067-z · Cited by 320
The lung as a privileged site for the beneficial actions of PGE2
Vancheri, C. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.001 · Cited by 313
Macrophages and post-burn immune dysfunction
Schwacha, M. G. (2003) · Burns · doi:10.1016/s0305-4179(02)00187-0 · Cited by 310
Brock, T. G., McNish, R. W., & Peters-Golden, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11660 · Cited by 304
Velupillai, P., & Harn, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.18 · Cited by 299
Antioxidants and immune response in aged persons: overview of present evidence
Meydani, S., Wu, D., Santos, M., & Hayek, M. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1462s · Cited by 298
Prostaglandins and chronic inflammation
Aoki, T., & Narumiya, S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.02.004 · Cited by 291
D’Avila, H., Melo, R. C. N., Parreira, G. G., Werneck-Barroso, E., Castro-Faria-Neto, H. C., & Bozza, P. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3087 · Cited by 289
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R. B., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13640 · Cited by 287
IL-18–induced CD83+CCR7+NK helper cells
Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., & Kalinski, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050128 · Cited by 286
Prostaglandin‐cytokine crosstalk in chronic inflammation
Yao, C., & Narumiya, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14530 · Cited by 283
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113640 · Cited by 278
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Wu, A. A., Drake, V., Huang, H.-S., Chiu, S., & Zheng, L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1016700 · Cited by 271
Newberry, R. D., Stenson, W. F., & Lorenz, R. G. (1999) · Nature Medicine · doi:10.1038/11341 · Cited by 264
Laan, W., Grobbee, D. E., Selten, J.-P., Heijnen, C. J., Kahn, R. S., & Burger, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05117yel · Cited by 264
Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases
Tsuge, K., Inazumi, T., Shimamoto, A., & Sugimoto, Y. (2019) · International Immunology · doi:10.1093/intimm/dxz021 · Cited by 263
Premature Ovarian Failure and Ovarian Autoimmunity
Hoek, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.1.107 · Cited by 259
Sympathetic modulation of immunity: Relevance to disease
Bellinger, D. L., Millar, B. A., Perez, S., Carter, J., Wood, C., ThyagaRajan, S., Molinaro, C., Lubahn, C., & Lorton, D. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.005 · Cited by 254
Regulation of Candida albicans Morphogenesis by Fatty Acid Metabolites
Noverr, M. C., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6206-6210.2004 · Cited by 254
Is resolution the end of inflammation?
Feehan, K. T., & Gilroy, D. W. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.006 · Cited by 229
Trebble, T. M., Wootton, S. A., Miles, E. A., Mullee, M., Arden, N. K., Ballinger, A. B., Stroud, M. A., Burdge, G. C., & Calder, P. C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.376 · Cited by 179
Role of PLB1 in Pulmonary Inflammation and Cryptococcal Eicosanoid Production
Noverr, M. C., Cox, G. M., Perfect, J. R., & Huffnagle, G. B. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1538-1547.2003 · Cited by 133
Age-associated alterations in immune function and inflammation
Lewis, E. D., Wu, D., & Meydani, S. N. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110576 · Cited by 111
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
Dohmen, K., Mizuta, T., Nakamuta, M., Shimohashi, N., Ishibashi, H., & Yamamoto, K. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i6.894 · Cited by 99
Calder, P. C. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.11.003 · Cited by 81
Brown, F. F., Bigley, A. B., Sherry, C., Neal, C. M., Witard, O. C., Simpson, R. J., & Galloway, S. D. R. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.031 · Cited by 42
Vascular endothelial cell activation by adult Dirofilaria immitis antigens
Morchón, R., Rodríguez-Barbero, A., Velasco, S., López-Belmonte, J., & Simón, F. (2008) · Parasitology International · doi:10.1016/j.parint.2008.05.004 · Cited by 27
Dirofilaria immitis and Wolbachia-derived antigens: Its effect on endothelial mammal cells
Simón, F., Morchón, R., Rodríguez-Barbero, A., López-Belmonte, J., Grandi, G., & Genchi, C. (2008) · Veterinary Parasitology · doi:10.1016/j.vetpar.2008.09.010 · Cited by 21
Morchón, R., Roca, F., López-Belmonte, J., Genchi, M., Venco, L., Rodríguez-Barbero, A., & Simón, F. (2007) · Veterinary Parasitology · doi:10.1016/j.vetpar.2007.04.010 · Cited by 12
Metadata
- Authors
- Betz, M., & Fox, B. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-01-01
- Volume
- 146
- Issue
- 1
- Pages
- 108-113
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1553386677
- Cited by
- 821
- References
- 0
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.